Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Blumberg

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Molecular Interventions|January 18, 2008
Lighting a backfire to quench the blaze: a combined drug approach targeting the vanilloid receptor TRPV1Peter M Blumberg
Temperature (Austin, Tex.)|May 27, 2016
To not be hot when TRPV1 is notPeter M Blumberg
Accounts of Chemical Research|June 18, 2003
Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C)Victor E Marquez, Peter M Blumberg
Vitamins and Hormones|August 4, 2009
Anandamide and the vanilloid receptor (TRPV1)Attila Tóth, Peter M Blumberg, Judit Boczán
Current Topics in Medicinal Chemistry|June 16, 2011
TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulationPeter M Blumberg, Larry V Pearce, Jeewoo Lee
Current Opinion in Neurobiology|July 26, 2002
Endovanilloid signaling in painVincenzo Di Marzo, Peter M Blumberg, Arpad Szallasi
Antiviral Research|August 5, 2003
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetateSven Bocklandt, Peter M Blumberg, Dean H Hamer
Cancer Research|July 20, 2006
Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase CdeltaSung Hee Choi, Tehila Hyman, Peter M Blumberg
Life Sciences|May 22, 2003
Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the ratAttila Tóth, Noémi Kedei, Yun Wang, et al.
The Journal of Biological Chemistry|December 22, 2004
Analysis by fluorescence resonance energy transfer of the interaction between ligands and protein kinase Cdelta in the intact cellDerek C Braun, Susan H Garfield, Peter M Blumberg
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Molecular Interventions|January 18, 2008
Lighting a backfire to quench the blaze: a combined drug approach targeting the vanilloid receptor TRPV1Peter M Blumberg
Temperature (Austin, Tex.)|May 27, 2016
To not be hot when TRPV1 is notPeter M Blumberg
Accounts of Chemical Research|June 18, 2003
Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C)Victor E Marquez, Peter M Blumberg
Vitamins and Hormones|August 4, 2009
Anandamide and the vanilloid receptor (TRPV1)Attila Tóth, Peter M Blumberg, Judit Boczán
Current Topics in Medicinal Chemistry|June 16, 2011
TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulationPeter M Blumberg, Larry V Pearce, Jeewoo Lee
Current Opinion in Neurobiology|July 26, 2002
Endovanilloid signaling in painVincenzo Di Marzo, Peter M Blumberg, Arpad Szallasi
Antiviral Research|August 5, 2003
Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetateSven Bocklandt, Peter M Blumberg, Dean H Hamer
Cancer Research|July 20, 2006
Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase CdeltaSung Hee Choi, Tehila Hyman, Peter M Blumberg
Life Sciences|May 22, 2003
Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the ratAttila Tóth, Noémi Kedei, Yun Wang, et al.
The Journal of Biological Chemistry|December 22, 2004
Analysis by fluorescence resonance energy transfer of the interaction between ligands and protein kinase Cdelta in the intact cellDerek C Braun, Susan H Garfield, Peter M Blumberg
Pageof 19